REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Centro De Enfermedades Gastrointestinales Del Cesar Gastrocesar S.A.S. (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Centro De Enfermedades Gastrointestinales Del Cesar Gastrocesar S.A.S. Profile Updated: September 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Centro De Enfermedades Gastrointestinales Del Cesar Gastrocesar S.A.S. is an enterprise in Colombia, with the main office in Valledupar. The company operates in the Ambulatory Health Care Services sector. The company was established on April 11, 2007. The total number of employees is currently 13 (2017). The latest financial highlights indicate a net sales revenue increase of 140.64% in 2022. Its’ total assets recorded a growth of 8.78%.

Headquarters
Cr 10 12 51
Valledupar; Cesar;

Contact Details: Purchase the Centro De Enfermedades Gastrointestinales Del Cesar Gastrocesar S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Centro De Enfermedades Gastrointestinales Del Cesar Gastrocesar S.A.S. report to view the information.
Outstanding Shares:
Purchase the Centro De Enfermedades Gastrointestinales Del Cesar Gastrocesar S.A.S. report to view the information.
Incorporation Date:
April 11, 2007
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Centro De Enfermedades Gastrointestinales Del Cesar Gastrocesar S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
140.64%▲
Total operating revenue
140.64%▲
Operating profit (EBIT)
595.94%▲
EBITDA
261.51%▲
Net Profit (Loss) for the Period
N/A
Total assets
8.78%▲
Total equity
81.44%▲
Operating Profit Margin (ROS)
5.33%▲
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0.89%▲
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo